Transactions by QIAGEN N.V. (QGEN) in the last 6 months

Qiagen NV (NASDAQ: QGEN) acquired Ingenuity Systems, Inc. for approximately $110 million in cash on April 29, 2013. Transaction has been funded from existing cash reserves. Ingenuity reported net sales of approximately $20 million, for the year ending December 31, 2012. Many members of Ingenuity's senior management team, including Jake Leschly, will continue with QIAGEN, and the offices will remain in Redwood City, California. The transaction is expected to be dilutive ... to full-year 2013 adjusted diluted EPS by approximately $0.03 per share and to 2014 adjusted diluted EPS by approximately $0.02 per share, and become accretive in 2015. Jefferies & Company, Inc. acted as exclusive financial advisor to Ingenuity Systems.
Read More

Drug Response Dx GmbH announced that it has received its seed round of funding from new investors Qiagen NV and High-Tech Gründerfonds Management GmbH on January 7, 2013. Qiagen NV has made a strategic equity investment in the company. The terms of the transaction were not disclosed. High-Tech Gründerfonds Management GmbH invested through its fund High-Tech Gründerfonds II GmbH und Co. KG.

Sponsored Financial Commentaries

To contact QIAGEN N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.